ARCHIVES OF

THE BALKAN MEDICAL UNION

The official journal of the Balkan Medical Union, since 1935

Citation Abbreviation:

Arch Balk Med Union

Expression of CD8, CD68 and HER2 markers in breast carcinoma in diabetes patients

0

Introduction. Type 2 diabetes mellitus (T2DM) is recognized as a risk factor for breast cancer, potentially influencing tumour aggressiveness and immune response through the tumour microenvironment (TME).
The objective of the study was to evaluate the expression of immune markers such as CD8, CD68 and HER2/neu receptor in the TME of invasive breast carcinoma in diabetes compared to non-diabetes patients.
Material and methods. The study included invasive breast carcinoma patients with T2DM (n=29) and without T2DM (n=43), from the Oncological Institute of Republic of Moldova, between 2018–2020. Immunohistochemical (IHC) analysis evaluated the expression of CD8, CD68, HER2/neu markers. Statistical analysis aimed the mean, median and associations with clinicopathological features. 
Results. In patients with T2DM, the TME showed a significantly lower density of intratumoural CD8+ T lymphocytes (mean 15.2 vs 17.5 in non-diabetics, p=0.0005) and a significantly higher infiltration of intratumoural CD68+ macrophages (mean 10.61 vs 9.5 in non-diabetics, p=0.02). Although overall HER2 expression was comparable between the groups, correlation analysis revealed significant, diabetes-specific associations. In the T2DM cohort, intratumoural CD8+ cells positively correlated with perineural invasion (r=0.42, p=0.01), and intratumoural CD68+ macrophages strongly correlated with nodal extension (pN) (r=0.42, p=0.01). 
Conclusions. T2DM induces significant alterations in immune cell populations and molecular interactions within the breast carcinoma TME. These diabetes-specific changes suggest distinct tumour biology, emphasizing the necessity for personalized therapeutic strategies in diabetes patients with breast cancer.
Keywords: HER2/neu, tumour microenvironment, type 2 diabetes mellitus, breast carcinoma.

Address for correspondence:
Ecaterina FOCA
Department of Histology, Cytology and Embryology, Nicolae Testemitanu State University of Medicine and Pharmacy
Address: Stefan cel Mare str. 192, Chisinau, MD-2004, Republic of Moldova
E-mail: ecaterina.foca@usmf.md; Phone +373-60033099

Share.

Comments are closed.

Brinza D, Foca E, David V, Carpenco E, Saptefrati L, Fulga V. Expression of CD8, CD68 and HER2 markers in breast carcinoma in diabetes patients. Arch Balk Med Union. 2025;60(4):509-518. https://doi.org/10.31688/ABMU.2025.60.4.07